Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population

Frontiers in Physiology

Volumn 3 JAN, Issue , 2013, Pages

  Lê, Kim Anne ^a,b   Li, Yan ^a,c   Xu, Xiaojing ^a   Yang, Wanting ^a,c   Liu, Tingting ^a   Zhao, Xiaoning ^a,c,d   Tang, Yongming Gorge ^a,d   Cai, Dehong ^a   Go, Vay Liang W ^a,e,f   Pandol, Stephen ^a,d,e,f   Hui, Hongxiang ^a,c,e,f  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c Dongguan SMU Metabolic Medicine Inc Ltd   (China)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gut; Metabolic diseases; Microbiota; Microflora

Indexed keywords

ACARBOSE; BACTERIAL DNA; CHINESE DRUG; GLIBENCLAMIDE; HEMOGLOBIN A1C; METFORMIN;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; BODY MASS; CHINA; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMMENSAL; CONTROLLED STUDY; DIABETIC PATIENT; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE DURATION; FECES MICROFLORA; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LIFESTYLE MODIFICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84874579981     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00496     Document Type: Article

References (20)

1. Andersson, A. F., Lindberg, M., Jakobsson, H., Backhed, F., Nyren, P., and Engstrand, L. (2008). Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS ONE 3:e2836. doi: 10. 1371/journal. pone. 0002836
2. Armougom, F., Henry, M., Vialettes, B., Raccah, D., and Raoult, D. (2009). Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4:e7125. doi: 10. 1371/journal. pone. 0007125
3. Arumugam, M., Raes, J., Pelletier, E., Le, P. D., Yamada, T., Mende, D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174-180.
4. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101, 15718-15723.
5. Byun, R., Nadkarni, M. A., Chhour, K. L., Martin, F. E., Jacques, N. A., and Hunter, N. (2004). Quantitative analysis of diverse Lactobacillus species present in advanced dental caries. J. Clin. Microbiol. 42, 3128-3136.
6. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes 57, 1470-1481.
7. Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., et al. (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.
8. Delzenne, N. M., and Cani, P. D. (2011). Gut microbiota and the pathogenesis of insulin resistance. Curr. Diab. Rep. 11, 154-159.
9. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
10. Haarman, M., and Knol, J. (2006). Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 72, 2359-2365.
11. Larsen, N., Vogensen, F. K., van den Berg, F. W., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., et al. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085. doi: 10. 1371/journal. pone. 0009085
12. Matsuki, T., Watanabe, K., Tanaka, R., and Oyaizu, H. (1998). Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted speciesand group-specific primers. FEMS Microbiol. Lett. 167, 113-121.
13. Naito, E., Yoshida, Y., Makino, K., Kounoshi, Y., Kunihiro, S., Takahashi, R., et al. (2011). Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J. Appl. Microbiol. 110, 650-657.
14. Russell, D. A., Ross, R. P., Fitzgerald, G. F., and Stanton, C. (2011). Metabolic activities and probiotic potential of bifidobacteria. Int. J. Food Microbiol. 149, 88-105.
15. Santacruz, A., Marcos, A., Warnberg, J., Marti, A., Martin-Matillas, M., Campoy, C., et al. (2009). Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring) 17, 1906-1915.
16. Tremaroli, V., Kovatcheva-Datchary, P., and Backhed, F. (2010). A role for the gut microbiota in energy harvesting? Gut 59, 1589-1590.
17. Wellen, K. E., and Hotamisligil, G. S. (2005). Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119.
18. Wu, J., Wang, X., Cai, W., Hong, L., and Tang, Q. (2010a). Bifidobacterium adolescentis supplementation ameliorates parenteral nutrition-induced liver injury in infant rabbits. Dig. Dis. Sci. 55, 2814-2820.
19. Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., et al. (2010b). Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61, 69-78.
20. Zeuthen, L. H., Christensen, H. R., and Frokiaer, H. (2006). Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin. Vaccine Immunol. 13, 365-375.